[High-fat diet induces pulmonary fibrosis in rats and inhibitory effects of N-acetylcysteine]. 2013

Hong-zhi Yu, and Qi Wu, and Zhong-zhen Du, and Xin Sun, and Cheng-zhi Wang, and Li Li
Department of Respiratory Medicine, Tianjin Haihe Hospital, Institute of Respiratory Medicine Tianjin, Tianjin 300350, China.

OBJECTIVE To explore the relation between high-fat diet and pulmonary fibrosis and the inhibition of N-acetylcysteine (NAC) on lung tissue in rats. METHODS Thirty Sprague Dawley (SD) male rats were randomly divided into control group (n = 10) on a quantitative control Lieber-DeCarli liquid diet, a high-fat diet group (n = 10) on a high fat-diet Lieber-DeCarli liquid diet and NAC group (n = 10) on NAC 300 mg×kg(-1)×d(-1). All rats were sacrificed 8 weeks later. The morphological changes and collagen deposition in lung tissue were observed by hematoxylin & eosin and Masson staining while the contents of glutathione (GSH) and hyaluronic acid (HA) measured through colorimetry and enzyme-linked immunosorbent assay. And the expression of transforming growth factor-β1 (TGF-β1) expression in lung tissue was detected through immunohistochemistry. RESULTS There were variable degree of alveolar and alveolar septal infiltration of inflammatory cells. And more deposition of collagen fibers appeared at intervals of alveolar in high fat group. Similar pathological changes were found in NAC group, but the degree was lower than that of high-fat group. Compared to the control and NAC groups, the lung tissue content of GSH decreased (GSH: 0.11 ± 0.05 vs 0.19 ± 0.11, 0.22 ± 0.14 mg/g, both P < 0.05) while HA and TGF-β1 increased in high-fat diet group (HA: 0.57 ± 0.06 vs 0.46 ± 0.04, 0.41 ± 0.04 mg/g; TGF-β1: 24.6 ± 3.4 vs 16.8 ± 2.6, 11.7 ± 1.5, all P < 0.05). CONCLUSIONS High-fat diet may induce pulmonary fibrosis in rats and NAC has inhibitory effects.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D011658 Pulmonary Fibrosis A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death. Alveolitis, Fibrosing,Idiopathic Diffuse Interstitial Pulmonary Fibrosis,Fibroses, Pulmonary,Fibrosis, Pulmonary,Pulmonary Fibroses,Alveolitides, Fibrosing,Fibrosing Alveolitides,Fibrosing Alveolitis
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000111 Acetylcysteine The N-acetyl derivative of CYSTEINE. It is used as a mucolytic agent to reduce the viscosity of mucous secretions. It has also been shown to have antiviral effects in patients with HIV due to inhibition of viral stimulation by reactive oxygen intermediates. Mercapturic Acid,Acemuc,Acetabs,Acetylcystein AL,Acetylcystein Atid,Acetylcystein Heumann,Acetylcystein Trom,Acetylcysteine Hydrochloride,Acetylcysteine Sodium,Acetylcysteine Zinc,Acetylcysteine, (D)-Isomer,Acetylcysteine, (DL)-Isomer,Acetylcysteine, Monoammonium Salt,Acetylcysteine, Monosodium Salt,Acetylin,Acetyst,Acétylcystéine GNR,Airbron,Alveolex,Azubronchin,Bisolvon NAC,Bromuc,Broncho-Fips,Broncholysin,Broncoclar,Codotussyl,Cystamucil,Dampo Mucopect,Eurespiran,Exomuc,Fabrol,Fluimucil,Fluprowit,Frekatuss,Genac,Hoestil,Ilube,Jenacystein,Jenapharm,Lantamed,Larylin NAC,Lindocetyl,M-Pectil,Muciteran,Muco Sanigen,Mucomyst,Mucosil,Mucosol,Mucosolvin,N-Acetyl-L-cysteine,N-Acetylcysteine,NAC AL,NAC Zambon,Optipect Hustengetränk,Siccoral,Siran,Solmucol,acebraus,durabronchal,mentopin Acetylcystein,Acetylcystein, mentopin,Acid, Mercapturic,Broncho Fips,BronchoFips,Hustengetränk, Optipect,Hydrochloride, Acetylcysteine,M Pectil,MPectil,Monoammonium Salt Acetylcysteine,Monosodium Salt Acetylcysteine,Mucopect, Dampo,N Acetyl L cysteine,N Acetylcysteine,NAC, Bisolvon,Sanigen, Muco,Sodium, Acetylcysteine,Zambon, NAC,Zinc, Acetylcysteine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D053773 Transforming Growth Factor beta1 A subtype of transforming growth factor beta that is synthesized by a wide variety of cells. It is synthesized as a precursor molecule that is cleaved to form mature TGF-beta 1 and TGF-beta1 latency-associated peptide. The association of the cleavage products results in the formation a latent protein which must be activated to bind its receptor. Defects in the gene that encodes TGF-beta1 are the cause of CAMURATI-ENGELMANN SYNDROME. TGF-beta1,Transforming Growth Factor-beta1,TGF-beta-1,TGF-beta1 Latency-Associated Protein,TGF-beta1LAP,Transforming Growth Factor beta 1 Latency Associated Peptide,Transforming Growth Factor beta I,Latency-Associated Protein, TGF-beta1,TGF beta 1,TGF beta1 Latency Associated Protein,TGF beta1LAP
D059305 Diet, High-Fat Consumption of excessive DIETARY FATS. Diet, High Fat,Diets, High Fat,Diets, High-Fat,High Fat Diet,High Fat Diets,High-Fat Diet,High-Fat Diets

Related Publications

Hong-zhi Yu, and Qi Wu, and Zhong-zhen Du, and Xin Sun, and Cheng-zhi Wang, and Li Li
August 2021, The European journal of neuroscience,
Hong-zhi Yu, and Qi Wu, and Zhong-zhen Du, and Xin Sun, and Cheng-zhi Wang, and Li Li
August 2016, Pharmaceutical research,
Hong-zhi Yu, and Qi Wu, and Zhong-zhen Du, and Xin Sun, and Cheng-zhi Wang, and Li Li
November 2022, Experimental physiology,
Hong-zhi Yu, and Qi Wu, and Zhong-zhen Du, and Xin Sun, and Cheng-zhi Wang, and Li Li
August 2015, Metabolism: clinical and experimental,
Hong-zhi Yu, and Qi Wu, and Zhong-zhen Du, and Xin Sun, and Cheng-zhi Wang, and Li Li
April 2015, Hepatology research : the official journal of the Japan Society of Hepatology,
Hong-zhi Yu, and Qi Wu, and Zhong-zhen Du, and Xin Sun, and Cheng-zhi Wang, and Li Li
March 2020, Iranian journal of basic medical sciences,
Hong-zhi Yu, and Qi Wu, and Zhong-zhen Du, and Xin Sun, and Cheng-zhi Wang, and Li Li
May 2012, The New England journal of medicine,
Hong-zhi Yu, and Qi Wu, and Zhong-zhen Du, and Xin Sun, and Cheng-zhi Wang, and Li Li
August 2012, The New England journal of medicine,
Hong-zhi Yu, and Qi Wu, and Zhong-zhen Du, and Xin Sun, and Cheng-zhi Wang, and Li Li
August 2012, The New England journal of medicine,
Hong-zhi Yu, and Qi Wu, and Zhong-zhen Du, and Xin Sun, and Cheng-zhi Wang, and Li Li
August 2012, The New England journal of medicine,
Copied contents to your clipboard!